ADARx Pharmaceuticals to Showcase at the 23rd Annual Global Healthcare Conference Hosted by Morgan Stanley
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Source: Globenewswire
Company Participation: ADARx Pharmaceuticals will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, with Dr. Zhen Li, President and CEO, speaking at 3:20 p.m. EDT.
Company Overview: ADARx is a late-stage clinical biotechnology company focused on developing RNA therapeutics for various diseases, including genetic, cardiovascular, and metabolic conditions, and has a collaboration with AbbVie for siRNA therapeutics.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
